Thrombin Generation Time (TGT) is an overall hemostasis test that measures the time and amount of thrombin generated in platelet-rich or platelet-poor plasma.

This test covers 4 important parameters which makes it possible to estimate the potential of an individual to generate thrombin and can individualize hyper or hypo-coagulable phenotypes. This test is also used to monitor conventional treatments for hemophilia and when using bypass therapy which is necessary when inhibitors develop in patients.